In these models, CXCL-9, IFN- γ, and MMP-1 were the most influential IRPs to differentiate CD patients from non-IBD controls (Figure 3A), all of which were higher in patients with CD than non-IBD controls. The gene discussed is MMP1; the disease is inflammatory bowel disease.